论文部分内容阅读
肺炎支原体(MP)感染是临床上最常见的小儿呼吸道感染性疾病,已经占到小儿呼吸道感染的5%~20%。为了探究治疗小儿支原体感染性肺炎的有效疗法,笔者将阿奇霉素经肺俞穴通过声介导药物靶向递送技术导入患儿体内,观察其疗效及安全性。1资料与方法1.1临床资料收集2013年10月到2016年6月本院儿科医治的支原体感染性肺炎患儿400例,按照给药方法不同分为治疗组及对照组,各200例。2组患
Mycoplasma pneumoniae (MP) infection is the most common clinical respiratory tract infection in children, has accounted for 5% of children with respiratory tract infections 20%. In order to explore effective treatment of children with Mycoplasma pneumoniae infection, the author will azithromycin Shushu acupuncture points through the drug-mediated drug delivery technology into the body of the child, to observe its efficacy and safety. 1 Materials and Methods 1.1 Clinical data collection 400 cases of pediatric patients with Mycoplasma pneumoniae pneumonia treated in our hospital from October 2013 to June 2016, divided into treatment group and control group, 200 cases each according to different administration methods. 2 groups of patients